[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fSddANp5QjOI0zSexYr2e7AL4KFNcS6A7Ua6F6gAa4G8":3,"$fiuQQyOEgUI7GgCjrzweJO1esXDuZrslK2ERIOqKZgs4":123},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},31607,"roche-pharma-ag","Roche Pharma AG",null,"DEU","ted-v3","https://ted.europa.eu/de/notice/-/detail/400910-2025","2026-06-11 10:03:32","2026-07-20 02:00:52",13,884000,"2025-06-20T00:00:00.000Z",[18,32,43,50,56,67,70,80,90,93,104,108,114],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":11,"award_notice_type":22,"award_date":8,"publication_date":16,"lot_number":8,"contract_title":23,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":27,"buyer_name":28,"region_code":29,"cpv_code":30,"tender_published_at_utc":31,"tender_deadline_utc":8},70051,25189,"400910-2025","can-standard","Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der Roche Pharma AG zu Hemlibra",0.92,"public","free","Deutschland – Arzneimittel – Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Novartis Pharma GmbH zu Rhapsido","IKK classic","DE","33600000","2026-05-27T22:00:00.000Z",{"award_id":33,"tender_id":34,"source_name":10,"source_award_id":35,"source_url":36,"award_notice_type":22,"award_date":8,"publication_date":37,"lot_number":8,"contract_title":38,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":39,"buyer_name":40,"region_code":41,"cpv_code":30,"tender_published_at_utc":42,"tender_deadline_utc":8},75493,77002,"330002-2025","https://ted.europa.eu/de/notice/-/detail/330002-2025","2025-05-22T00:00:00.000Z","Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu dem Wirkstoff Emicizumab","Deutschland – Arzneimittel – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu dem Wirkstoff Emicizumab","AOK Baden-Württemberg","DE-BW","2025-05-21T22:00:00.000Z",{"award_id":44,"tender_id":34,"source_name":10,"source_award_id":35,"source_url":36,"award_notice_type":22,"award_date":8,"publication_date":37,"lot_number":45,"contract_title":38,"winner_name":7,"winner_identifier":46,"winner_country":9,"value_eur":47,"currency":48,"confidence":49,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":39,"buyer_name":40,"region_code":41,"cpv_code":30,"tender_published_at_utc":42,"tender_deadline_utc":8},264371,"LOT-0001","DE142378777",221000,"EUR",0.97,{"award_id":51,"tender_id":20,"source_name":10,"source_award_id":52,"source_url":53,"award_notice_type":22,"award_date":8,"publication_date":54,"lot_number":8,"contract_title":55,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":27,"buyer_name":28,"region_code":29,"cpv_code":30,"tender_published_at_utc":31,"tender_deadline_utc":8},99902,"965-2025","https://ted.europa.eu/de/notice/-/detail/965-2025","2025-01-02T00:00:00.000Z","Abschluss eines nicht-exklusiven Rabattvertrages gemäß §130a Abs. 8 SGB V zwischen der IKK classic und der Roche Pharma AG zu PiaSky (R)",{"award_id":57,"tender_id":58,"source_name":10,"source_award_id":59,"source_url":60,"award_notice_type":22,"award_date":8,"publication_date":61,"lot_number":8,"contract_title":62,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":63,"buyer_name":64,"region_code":65,"cpv_code":30,"tender_published_at_utc":66,"tender_deadline_utc":8},103348,98171,"765424-2024","https://ted.europa.eu/de/notice/-/detail/765424-2024","2024-12-13T00:00:00.000Z","BvA_Patent_80.2","Deutschland – Arzneimittel – BvA_Patent_80.2","GWQ ServicePlus AG","DE-NW","2024-12-12T23:00:00.000Z",{"award_id":68,"tender_id":58,"source_name":10,"source_award_id":59,"source_url":60,"award_notice_type":22,"award_date":8,"publication_date":61,"lot_number":45,"contract_title":62,"winner_name":7,"winner_identifier":69,"winner_country":9,"value_eur":8,"currency":8,"confidence":49,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":63,"buyer_name":64,"region_code":65,"cpv_code":30,"tender_published_at_utc":66,"tender_deadline_utc":8},181175,"HRA 410096",{"award_id":71,"tender_id":72,"source_name":10,"source_award_id":73,"source_url":74,"award_notice_type":22,"award_date":8,"publication_date":75,"lot_number":76,"contract_title":77,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":47,"currency":48,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":78,"buyer_name":40,"region_code":41,"cpv_code":30,"tender_published_at_utc":79,"tender_deadline_utc":8},115561,107356,"614507-2024","https://ted.europa.eu/de/notice/-/detail/614507-2024","2024-10-11T00:00:00.000Z","3","Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)","Deutschland – Arzneimittel – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)","2024-10-10T22:00:00.000Z",{"award_id":81,"tender_id":82,"source_name":10,"source_award_id":83,"source_url":84,"award_notice_type":22,"award_date":8,"publication_date":85,"lot_number":8,"contract_title":86,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":87,"buyer_name":88,"region_code":65,"cpv_code":30,"tender_published_at_utc":89,"tender_deadline_utc":8},127639,116836,"454531-2024","https://ted.europa.eu/de/notice/-/detail/454531-2024","2024-07-29T00:00:00.000Z","Vertragsabschluss zum Arzneimittelwirkstoff Faricimab, Verkaufsname: Vabysmo, Unternehmen Roche Pharma AG","Deutschland – Arzneimittel – Vertragsabschluss zum Arzneimittelwirkstoff Faricimab, Verkaufsname: Vabysmo, Unternehmen Roche Pharma AG","AOK Rheinland/Hamburg - Die Gesundheitskasse","2024-07-28T22:00:00.000Z",{"award_id":91,"tender_id":82,"source_name":10,"source_award_id":83,"source_url":84,"award_notice_type":22,"award_date":8,"publication_date":85,"lot_number":45,"contract_title":86,"winner_name":7,"winner_identifier":92,"winner_country":9,"value_eur":8,"currency":8,"confidence":49,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":87,"buyer_name":88,"region_code":65,"cpv_code":30,"tender_published_at_utc":89,"tender_deadline_utc":8},239068,"Registergericht: Freiburg i. Br. HRB 412761",{"award_id":94,"tender_id":95,"source_name":10,"source_award_id":96,"source_url":97,"award_notice_type":22,"award_date":8,"publication_date":98,"lot_number":8,"contract_title":99,"winner_name":100,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":101,"buyer_name":102,"region_code":103,"cpv_code":30,"tender_published_at_utc":98,"tender_deadline_utc":8},129418,118254,"427577-2024","https://ted.europa.eu/de/notice/-/detail/427577-2024","2024-07-17T00:00:00.000Z","Ocrevus (Wirkstoff: Ocrelizumab), ATC L04AG08","Roche Pharma GmbH","Deutschland – Arzneimittel – Arzneimittelrahmenrabattvertrag gemäß § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Ocrevus (Wirkstoff: Ocrelizumab), ATC L04AG08","DAK-Gesundheit","DE-HH",{"award_id":105,"tender_id":95,"source_name":10,"source_award_id":96,"source_url":97,"award_notice_type":22,"award_date":8,"publication_date":98,"lot_number":45,"contract_title":106,"winner_name":100,"winner_identifier":107,"winner_country":9,"value_eur":8,"currency":8,"confidence":49,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":101,"buyer_name":102,"region_code":103,"cpv_code":30,"tender_published_at_utc":98,"tender_deadline_utc":8},243712,"Arzneimittelrahmenrabattvertrag gemäß § 130a Abs. 8 des Fünften Sozialgesetzbuchs - Ocrevus (Wirkstoff: Ocrelizumab), ATC L04AG08","000",{"award_id":109,"tender_id":110,"source_name":10,"source_award_id":111,"source_url":112,"award_notice_type":22,"award_date":8,"publication_date":113,"lot_number":76,"contract_title":77,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":47,"currency":48,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":78,"buyer_name":40,"region_code":41,"cpv_code":30,"tender_published_at_utc":113,"tender_deadline_utc":8},134124,121828,"368592-2024","https://ted.europa.eu/de/notice/-/detail/368592-2024","2024-06-21T00:00:00.000Z",{"award_id":115,"tender_id":116,"source_name":10,"source_award_id":117,"source_url":118,"award_notice_type":22,"award_date":8,"publication_date":119,"lot_number":120,"contract_title":121,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":47,"currency":48,"confidence":24,"visibility":25,"access_tier":26,"company_slug":6,"company_name":7,"website_url":8,"tender_title":122,"buyer_name":40,"region_code":41,"cpv_code":30,"tender_published_at_utc":119,"tender_deadline_utc":8},153460,137085,"66530-2024","https://ted.europa.eu/de/notice/-/detail/66530-2024","2024-02-01T00:00:00.000Z","2","Abschluss von nicht nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)","Deutschland – Arzneimittel – Abschluss von nicht nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)",{"company_slug":6,"years":124,"award_count":14,"top_buyers":125,"yearly_trend":140},5,[126,129,134,136,138],{"buyer_name":40,"buyer_key":127,"award_count":124,"total_value_eur":15,"share_count":128},"aok-baden-wuerttemberg",0.385,{"buyer_name":28,"buyer_key":130,"award_count":131,"total_value_eur":132,"share_count":133},"ikk-classic",2,0,0.154,{"buyer_name":64,"buyer_key":135,"award_count":131,"total_value_eur":132,"share_count":133},"gwq-serviceplus-ag",{"buyer_name":88,"buyer_key":137,"award_count":131,"total_value_eur":132,"share_count":133},"aok-rheinland-hamburg-die-gesundheitskasse",{"buyer_name":102,"buyer_key":139,"award_count":131,"total_value_eur":132,"share_count":133},"dak-gesundheit",[141,144],{"year":142,"award_count":143},2024,9,{"year":145,"award_count":146},2025,4]